@ARTICLE{
author={Armuzzi A,Atreya R,Sparrow MP,Markovic S,Le Berre C,Hlavaty T,Treton X,Cataldi F,Jacobstein D,Rabbat C,Shan K,Dubinsky MC},
year={2026},
title={Early symptomatic improvement with obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials},
journal={JOURNAL OF CROHNS & COLITIS},
volume={20},
number={},
pages={-},
document_type={Meeting Abstract},
}